Given the potential oncogenic role of SLC2A1 (GLUT1) in LUAD, we speculate whether indacaterol can affect the biological behavior of lung cancer cells by regulating SLC2A1 (GLUT1). The gene discussed is SLC2A1; the disease is lung carcinoma.